Skip to content

The Effect of Oxycodone Hydrochloride on CRBD After TURBT Under General Anesthesia

The Effect of Oxycodone Hydrochloride on Catheter-related Bladder Discomfort After TURBT Under General Anesthesia

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05510986
Enrollment
196
Registered
2022-08-22
Start date
2022-10-01
Completion date
2024-11-01
Last updated
2022-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of Drug, Adverse Effect of Opioids

Keywords

Oxycodone Hydrochloride, CRBD, TURBT, general anesthesia

Brief summary

The purpose of this study is to investigate the effect of Oxycodone Hydrochloride on catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor after general anesthesia.

Detailed description

Catheter-related bladder discomfort(CRBD) is a frequent complication after indwelling catheter under general anesthesia. The incidence of CRBD in patients undergoing Transurethral resection is as high as 66.7-91.2%.CRBD may lead some poor prognosis including postoperative restlessness, bleeding, and circulatory instability.therefore,how to reduce the incidence of CRBD is one of the urgent problems to be solved in clinic. Oxycodone Hydrochloride is a strong opioid receptor agonist used in clinic at present. It has certain advantages in the regulation of visceral pain and can produce analgesic effect without causing restlessness, gastrointestinal motility inhibition and respiratory inhibition through stimulating the μ and κ opioid receptor simultaneously. However, the effect of Oxycodone Hydrochloride on catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor after general anesthesia is still unknown. The purpose of this study is to explore whether Oxycodone Hydrochloride via intravenous injection could reduce the incidence of CRBD in patients undergoing transurethral resection of bladder tumor after general anesthesia and could not increase other complications during the recovery period of general anesthesiathe.

Interventions

Dilute fentanyl hydrochloride injection (1ml:0.1mg) with 0.9% normal saline to 10μg/ml, 1μg/kg fentanyl is slowly injected intravenously 10 minutes before the end of the operation, and the administration speed is not less than 5 minutes.

DRUGOxycodone Hydrochloride group

Dilute Oxycodone Hydrochloride injection (1ml:10mg) with 0.9% normal saline to 1mg/ml, 0.1mg/kg Oxycodone Hydrochloride is slowly injected intravenously 10 minutes before the end of the operation, and the administration speed is not less than 5 minutes.

Sponsors

General Hospital of Ningxia Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* More than 18 years old; * ASA I - III; * Plan to perform transurethral resection of bladder tumor under general anesthesia; ( * Agree to participate in this study and sign the informed consent form.

Exclusion criteria

* Refuse to participate in this study; * Emergency surgery; * Catheter was indwelling before operation; * Taking opioids for a long time before operation; * Previous history of schizophrenia, epilepsy, Parkinson's disease or myasthenia gravis; * Unable to communicate due to coma, severe dementia or language disorder before operation; * Critical condition (ASA grade ≥ IV before operation); Severe renal function damage (requiring renal replacement therapy); Severe liver function damage (child Pugh grade C); Acute stage of chronic obstructive pulmonary disease, severe asthma, severe pulmonary heart disease; * History of opioid allergy.

Design outcomes

Primary

MeasureTime frameDescription
The incidence of catheter-related bladder discomfort1 hourCRBD is symptoms vary among patients from burning sensation and pain in the suprapubic and penile areas to urinary urgency. 4 grades 0:No discomfort 1. Mild discomfort only reported upon questioning 2. Moderate discomfort, urge to pass urine reported by the patient without questioning 3. Severe discomfort, urge to pass urine accompanied by behavioral responses, such as flailing limbs, strong verbal responses, or attempt to pull out the catheter

Secondary

MeasureTime frameDescription
The incidence of Nausea and vomiting1 hourNausea refers to patients who have gastrointestinal symptoms but do not spit out stomach contents. Vomiting means that the patient has gastrointestinal symptoms and vomits stomach contents
Degree of sedation1 hourRamsay evaluation
Degree of pain1 hourNRS
the incidence of other complication1 hourRespiratory depression, itching, shivering

Countries

China

Contacts

Primary ContactNi xinli, MD
eleven87670@163.com13014260603
Backup ContactYin lingzi, MD
eleven87670@163.com13014260603

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026